The Changes in Coagulation and Fibrinolytic Activities in Acute Myocardial Infarction Patients Treated with Recombinant Tissue Plasminogen Activator and Urokinase.
10.4070/kcj.1998.28.5.700
- Author:
Jeongkee SEO
;
Dongsoo KIM
;
Huck Moon KWON
;
Injai KIM
;
Yangsoo JANG
;
Hyun Seung KIM
;
Kyungsoon SONG
- Publication Type:Original Article ; Randomized Controlled Trial
- Keywords:
Thrombolysis;
rt-PA;
Urokinase;
Thrombin-antithrombin III complex (TAT);
Plasmin-alpha2 plasmin inhibitor complex (PIC);
Protein C;
Protein S
- MeSH:
Antifibrinolytic Agents;
Fibrinogen;
Fibrinolytic Agents;
Humans;
Myocardial Infarction*;
Plasma;
Protein C;
Protein S;
Thrombolytic Therapy;
Tissue Plasminogen Activator*;
Urokinase-Type Plasminogen Activator*
- From:Korean Circulation Journal
1998;28(5):700-706
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The coagulation and fibrinolytic activities increase in the setting of acute myocardial infarction (AMI) and has been shown to increase further after the administration of thrombolytic agents. The reocclusion rate was slightly higher in patients with recombinant tissue type plasminogen activator (rt-PA) than urokinase (UK). However, there are few studies on serial changes in coagulation and fibrinolytic activities during the thrombolytic therapy. METHODS: Twenty five AMI patients who visited Yongdong Severance Hospital from August 1996 to August 1997 were recruited. They were randomized two groups either double bolus UK or accelerated rt-PA. Plasma levels of fibrinogen, thrombin-antithrombin III complex (TAT), plasmin-alpha2 plasmin inhibitor complex (PIC), activities of protein C and protein S were checked before and 3, 12, 24hrs and 7days after the thrombolytic therapy. RESULTS: Plasma level of fibrinogen was decreased 3 and 12hrs after the initiation of thrombolytic therapy in both groups (p<0.05) however, the fibrinogen level in UK treated group (59.9+/-33.5 mg/dl) was decreased than rt-PA treated group (198.2+/-64.3 mg/dl) at 3hrs after thrombolytic therapy (p<0.05). Activities of protein C and protein S were increased at 3hrs after thrombolytic therapy in both groups and no difference was noticed between UK and rt-PA group. Concentrations of TAT and PIC were increased in both groups even before the thrombolytic therapy was initiated. The increment of TAT level was larger in rt-PA group (21.7+/-16.1, 8.9+/-5.4 ng/mL) compared with UK group (15.0+/-17.9, 4.6+/-1.9 ng/mL) at 3 and 12 hrs after thrombolytic therapy (p<0.05). PIC level was significantly increased at 3 and 12 hrs after the treatment in both groups and no difference was noted between UK and rt-PA group. CONCLUSION: Both coagulation and fibrinolytic activities, activated already before thrombolytic therapy, were further aug-mented after thrombolytic therapy in AMI patients. The increment of fibrinolytic activity showed no significant difference between UK and rt-PA treated group. However the coagulation activity in rt-PA treated group was increased more than UK treated group.
